1IJR | pdb_00001ijr

Crystal structure of LCK SH2 complexed with nonpeptide phosphotyrosine mimetic


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 
    0.280 (Depositor) 
  • R-Value Work: 
    0.230 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 1IJR

This is version 1.3 of the entry. See complete history

Literature

A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.

Kawahata, N.Yang, M.G.Luke, G.P.Shakespeare, W.C.Sundaramoorthi, R.Wang, Y.Johnson, D.Merry, T.Violette, S.Guan, W.Bartlett, C.Smith, J.Hatada, M.Lu, X.Dalgarno, D.C.Eyermann, C.J.Bohacek, R.S.Sawyer, T.K.

(2001) Bioorg Med Chem Lett 11: 2319-2323

  • DOI: https://doi.org/10.1016/s0960-894x(01)00446-2
  • Primary Citation Related Structures: 
    1IJR

  • PubMed Abstract: 

    The novel phosphotyrosine (pTyr) mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp) has been designed and incorporated into a series of nonpeptide inhibitors of the SH2 domain of pp60(c-Src) (Src) tyrosine kinase. A 2.2 A X-ray crystal structure of 1a bound to a mutant form of Lck SH2 domain provides insight regarding the structure-activity relationships and supports the design concept of this new pTyr mimetic.


  • Organizational Affiliation
    • ARIAD Pharmaceuticals, Inc., Cambridge, MA 02139-4234, USA.

Macromolecule Content 

  • Total Structure Weight: 12.45 kDa 
  • Atom Count: 877 
  • Modeled Residue Count: 104 
  • Deposited Residue Count: 104 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK104Homo sapiensMutation(s): 0 
EC: 2.7.1.112 (PDB Primary Data), 2.7.10.2 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P06239 (Homo sapiens)
Explore P06239 
Go to UniProtKB:  P06239
PHAROS:  P06239
GTEx:  ENSG00000182866 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP06239
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
CC0

Query on CC0



Download:Ideal Coordinates CCD File
B [auth A](4-{2-ACETYLAMINO-2-[1-(3-CARBAMOYL-4-CYCLOHEXYLMETHOXY-PHENYL)-ETHYLCARBAMOYL}-ETHYL}-2-PHOSPHONO-PHENOXY)-ACETIC ACID
C29 H38 N3 O10 P
FXUGQWABROMTDA-SBUREZEXSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free:  0.280 (Depositor) 
  • R-Value Work:  0.230 (Depositor) 
Space Group: P 43 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 61.6α = 90
b = 61.6β = 90
c = 93.5γ = 90
Software Package:
Software NamePurpose
AMoREphasing
X-PLORrefinement
DENZOdata reduction
SCALEPACKdata scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2002-05-01
    Type: Initial release
  • Version 1.1: 2008-04-27
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2024-02-07
    Changes: Data collection, Database references, Derived calculations